Is prophylactic cranial irradiation indicated for patients with extensive-stage small cell lung cancer with a complete response to first-line treatment?
Prophylactic cranial irradiation (PCI) has been considered standard of care for patients with limited-stage small-cell lung cancer who achieve complete response to definitive treatment after a meta-analysis revealed its favorable effects on survival. In a European trial, PCI was also shown to confer a survival advantage for patients with extensive-stage (ES) SCLC who experienced any positive response after initial chemotherapy, leading to PCI also being considered a standard treatment for these patients as well.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Ryoko Suzuki, Ritsuko Komaki Tags: Editorial Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Radiology | Small Cell Lung Cancer